Institutional Ownership Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN). We have compiled data on the 210 institutions that hold shares in the stock, with a total of 102 Million shares, which have been reported (via 13F filing form) to have a value of $3.04 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Prudential Financial Inc
Newark, NJ |
Nov 13, 2024 Q3 2024 |
255,910
shares
|
$7.67 Million
0.01% of portfolio
|
Q3 2024
Added 1.13%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Nov 14, 2024 Q3 2024 |
248,320
shares
|
$7.45 Million
0.01% of portfolio
|
Q3 2024
Reduced 2.33%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
245,110
shares
|
$7.35 Million
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Ratan Capital Management LP
Miami Beach, FL |
Nov 14, 2024 Q3 2024 |
230,900
shares
|
$6.92 Million
2.34% of portfolio
|
Q2 2024
Added 696.21%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
212,900
shares
|
$6.38 Million
0.0% of portfolio
|
Q3 2024
Added 717.97%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
207,309
shares
|
$6.22 Million
0.0% of portfolio
|
Q3 2024
Added 162.21%
|
|
|
Axa S.A.
Paris, I0 |
Nov 14, 2024 Q3 2024 |
188,951
shares
|
$5.67 Million
0.02% of portfolio
|
Q3 2024
Reduced 10.09%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
184,211
shares
|
$5.52 Million
0.0% of portfolio
|
Q3 2024
Reduced 27.86%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
166,147
shares
|
$4.98 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.94%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
165,000
shares
|
$4.95 Million
0.36% of portfolio
|
Q3 2024
New holding
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
164,962
shares
|
$4.95 Million
0.02% of portfolio
|
Q3 2024
Added 13.47%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
160,000
shares
|
$4.8 Million
0.76% of portfolio
|
Q3 2024
Reduced 39.62%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
137,751
shares
|
$4.13 Million
0.42% of portfolio
|
Q3 2023
Reduced 54.2%
|
|
|
Neuberger Berman Group LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
137,066
shares
|
$4.11 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
134,334
shares
|
$4.03 Million
0.0% of portfolio
|
Q3 2024
Added 5.32%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
124,510
shares
|
$3.73 Million
0.0% of portfolio
|
Q3 2024
Added 2.4%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2024 Q3 2024 |
123,464
shares
|
$3.7 Million
0.01% of portfolio
|
Q3 2024
Added 16.83%
|
|
|
Artia Global Partners LP
Miami, FL |
Nov 14, 2024 Q3 2024 |
119,488
shares
|
$3.58 Million
1.17% of portfolio
|
Q1 2024
New holding
|
|
|
Crestline Management, LP
Fort Worth, TX |
Nov 13, 2024 Q3 2024 |
117,681
shares
|
$3.53 Million
0.22% of portfolio
|
Q3 2024
Added 27.37%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
117,500
shares
|
$3.52 Million
0.36% of portfolio
|
Q3 2024
Reduced 41.54%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
111,657
shares
|
$3.35 Million
0.0% of portfolio
|
Q3 2024
Added 70.35%
|
|
|
Td Asset Management Inc
|
Nov 01, 2024 Q3 2024 |
108,830
shares
|
$3.26 Million
0.0% of portfolio
|
Q3 2024
Reduced 28.5%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 13, 2024 Q3 2024 |
106,215
shares
|
$3.19 Million
0.0% of portfolio
|
Q3 2024
Reduced 15.87%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
105,100
shares
|
$3.15 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.76%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
104,517
shares
|
$3.13 Million
0.0% of portfolio
|
Q3 2024
Reduced 51.49%
|